GENZYME CORP Patent Applications Pending
63 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2022-12-22: Application PCTUS2022082213; Invention METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA; Applicant GENZYME CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2022-12-20: Application 63433873; Invention THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS; Applicant Genzyme Corporation; Status Provisional Application Expired.
- 2022-12-20: Application 63433866; Invention THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS AND MYASTHENIA GRAVIS; Applicant Genzyme Corporation; Status Provisional Application Expired.
- 2022-12-20: Application 63433853; Invention THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY DISEASE (MOGAD); Applicant Genzyme Corporation; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2022-12-22 | PCTUS2022082213 | METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | SHAUNA ANDERSSON JOSE BARTELT-HOFER PRONABESH DASMAHAPATRA | United States France United States | ||
| 2022-12-20 | 63433873 | THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS | Genzyme Corporation | Provisional Application Expired | Deborah Dukovic Sana Syed Timothy J. Turner | United States United States United States | ||
| 2022-12-20 | 63433866 | THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS AND MYASTHENIA GRAVIS | Genzyme Corporation | Provisional Application Expired | Sana Syed | United States | ||
| 2022-12-20 | 63433853 | THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY DISEASE (MOGAD) | Genzyme Corporation | Provisional Application Expired | Timothy J. Turner Erik Wallstroem | United States United States | ||
| 2022-12-20 | 63433824 | DRUG FORMULATIONS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-PHENOXYPHENYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE | Genzyme Corporation | Provisional Application Expired | Marilyn Calderone Caroline Viault | France France | ||
| 2022-12-16 | PCTUS2022081729 | PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS | GENZYME CORPORATION REVOLUTION MEDICINES, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | GUILLAUME BEGIS MARC BIANCIOTTO INGRID DEVILLERS YANN FORICHER ARIELLE GENEVOIS-BORELLA ADRIAN L. GILL ANDREAS KARLSSON ELENA S. KOLTUN | France France France France France United States France United States | ||
| 2022-12-13 | 63432169 | CRYSTALLINE FORMS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-PHENOXYPHENYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE AND DERIVATIVES THEREOF | Genzyme Corporation | Provisional Application Expired | Tim Owens Philippe Ochsenbein Krista Diaz | United States France United States | ||
| 2022-12-08 | 63431186 | SYSTEMS AND METHODS FOR MODELING THROMBIN-ANTITHROMBIN | Genzyme Corporation | Provisional Application Expired | Chanchala Kaddi Randolph Leiser Mengdi Tao Susana Zaph | United States United States United States United States | ||
| 2022-12-07 | 63386491 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN | Genzyme Corporation | Provisional Application Expired | Shauna Andersson Baisong Mei Fadi Shammas Christian Sussebach | United States United States Canada Germany | ||
| 2022-12-07 | 63386489 | METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA | Genzyme Corporation | Provisional Application Expired | José Bartelt-Hofer | France | ||
| 2022-11-16 | 63425998 | FLOCCULATION AAV PURIFICATION | Genzyme Corporation | Provisional Application Expired | Bruno Figueroa Qingxuan Li Junfen Ma Yuanli Song | United States United States United States United States | ||
| 2022-11-11 | PCTUS2022049695 | CRYSTALLINE IMIDAZO[4,5-B]PYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE IN TREATING MEDICAL CONDITIONS | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | BENOIT ROBERT | United States | ||
| 2022-11-09 | 63382985 | COMPOSITION AND METHODS FOR CLEANING | GENZYME CORPORATION | Provisional Application Expired | Joseph P. Kutzko | United States | ||
| 2022-11-03 | 63382227 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN | Genzyme Corporation | Provisional Application Expired | Shauna Andersson Baisong Mei Fadi Shammas Christian Sussebach | United States United States Canada Germany | ||
| 2022-11-03 | 63382223 | METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA | Genzyme Corporation | Provisional Application Expired | José Bartelt-Hofer | France | ||
| 2022-11-02 | 63421912 | SYSTEMS AND METHODS FOR MODELING THROMBIN-ANTITHROMBIN | Genzyme Corporation | Provisional Application Expired | Chanchala Kaddi Susana Zaph Randolph Leiser Mengdi Tao | United States United States United States United States | ||
| 2022-10-31 | PCTUS2022078999 | TREATMENT OF OSTEOGENESIS IMPERFECTA | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | PANTELEIMON D. MAVROUDIS NIKHIL PILLAI QINGPING WANG | United States United States United States | ||
| 2022-10-31 | 63420932 | METHODS FOR TREATING RECEPTOR-INTERACTING PROTEIN KINASE 1-MEDIATED DISEASES | Genzyme Corporation | Provisional Application Expired | Nazem Atassi Catherine Cantalloube Agnès Hincelin-Mery Donato Teutonico | United States France France France | ||
| 2022-10-31 | 18051468 | TREATMENT OF OSTEOGENESIS IMPERFECTA | Genzyme Corporation | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20230144192A1 | Panteleimon D. MAVROUDIS Nikhil PILLAI Qingping WANG | United States United States United States | DUFFY, PATRICIA ANN |
| 2022-10-28 | 63381499 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN IN PEDIATRIC PATIENTS | Genzyme Corporation | Provisional Application Expired | Shauna Andersson Pratik R. Bhagunde Sajida Iqbal Pranav Patel Stacey Poloskey Fadi Shammas | United States United States United States United States United States Canada | ||
| 2022-10-14 | 17918973 | ECLITASERTIB FOR USE IN TREATING CONDITIONS INVOLVING SYSTEMIC HYPERINFLAMMATORY RESPONSE | Genzyme Corporation | Advisory Action Mailed | US20230233576A1 | John CAMINIS Peter FLORIAN Keith HARRIS Dimitry OFENGEIM Sabine SCHNYDER Heribert STAUDINGER Matija ZELIC | United States Germany United States United States United States United States United States | HUTTER, GILLIAN A |
| 2022-10-12 | 18045995 | FGFR3 ANTIBODIES AND METHODS OF USE | GENZYME CORPORATION | Final Rejection Mailed | US20230303704A1 | Yves SABBAGH Yangde CHEN William BRONDYK Huawei QIU Sunghae PARK Ronnie WEI Yu QIU Yanfeng ZHOU Cendrine LEMOINE HyunSuk CHO | United States United States United States United States United States United States United States United States France United States | ALLEN, MARIANNE P |
| 2022-10-11 | 63415099 | SYSTEMS AND DEVICES FOR PRODUCING BIOLOGICAL PRODUCTS AND METHODS OF USING THE SAME | Genzyme Corporation | Provisional Application Expired | Kevin Brower Michael Coolbaugh Xhorxhi Gjoka Chad Varner Jason Walther | United States United States United States United States United States | ||
| 2022-10-11 | 63415027 | THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS | Genzyme Corporation | Provisional Application Expired | Deborah Dukovic Sana Syed Timothy J. Turner | United States United States United States | ||
| 2022-10-10 | 63414691 | METHODS OF OPTIMIZING DISSOLVED OXYGEN LEVELS IN CELL CULTURE | Genzyme Corporation | Provisional Application Expired | Ethan Disston Penner Charles Budde Jeffrey Swana | United States United States United States | ||
| 2022-10-07 | 63414452 | Product Formulation in Biological Manufacturing | Genzyme Corporation | Provisional Application Expired | Michael Coolbaugh Sushmitha Krishnan Rita Barral | United States United States United States | ||
| 2022-09-28 | 63410878 | APPARATUS FOR PRODUCING BIOLOGICALS | Genzyme Corporation | Provisional Application Expired | Michael Coolbaugh Chad Varner | United States United States | ||
| 2022-09-07 | 63404443 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | Genzyme Corporation Sionna Therapeutics | Provisional Application Expired | Mark Munson Junkai Liao Gregory Donald Hurlbut John E. Macor George Topalov Zhongli Gao Sukanthini Thurairatnam Bradford Hirth Andrew Good Roy Vaz Jinyu Liu Yi Li Anatoly Ruvinsky Michael Kothe David Borcherding Lothar Schwink Heiner Glombik Stefan Guessregen Michael Podeschwa Nils Rackelmann Sven Ruf | United States United States United States United States United States United States France France France France France France France France France France France France France France France | ||
| 2022-09-07 | 63404440 | COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | Genzyme Corporation Sionna Therapeutics | Provisional Application Expired | Mark Munson Junkai Liao Gregory Donald Hurlbut John E. Macor George Topalov Zhongli Gao Sukanthini Thurairatnam Bradford Hirth Andrew Good Roy Vaz Jinyu Liu Yi Li Anatoly Ruvinsky Michael Kothe David Borcherding Patrick Bernardelli Arielle Genevois Borella Franck Caussanel Ingrid Devillers Eric Nicolai Franck Slowinski Fabienne Thompson Lothar Schwink Heiner Glombik Stefan Guessregen Michael Podeschwa Nils Rackelmann Sven Ruf | United States United States United States United States United States United States France France France France France France France France France France France France France France France France France France France France France France | ||
| 2022-09-07 | 63404439 | MACROCYCLIC METHYLAMINES AND METHODS OF USING THE SAME | Genzyme Corporation Sionna Therapeutics | Provisional Application Expired | Mark Munson Junkai Liao Gregory Donald Hurlbut John E. Macor George Topalov Sukanthini Thurairatnam Bradford Hirth Zhongli Gao Andrew Good Roy Vaz Jinyu Liu Yi Li Anatoly Ruvinsky Michael Kothe David Borcherding Patrick Bernardelli Arielle Genevois Borella Franck Caussanel Ingrid Devillers Eric Nicolai Franck Slowinski Fabienne Thompson Lothar Schwink Heiner Glombik Stefan Guessregen Michael Podeschwa Nils Rackelmann Sven Ruf | United States United States United States United States United States France France United States France France France France France France France France France France France France France France France France France France France France | ||
| 2022-09-02 | PCTUS2022075945 | INDOLE COMPOUNDS AND METHODS OF USE | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | JUNKAI LIAO MARK MUNSON SUKANTHINI THURAIRATNAM BRADFORD HIRTH ZHONGLI GAO GREGORY HURLBUT DAVID BORCHERDING MATTHIEU BARRAGUE TIMOTHY ALAN GILLESPY ALEXANDRE GROSS ANDREW GOOD ROY VAZ JINYU LIU YI LI MARKUS METZ ANATOLY RUVINSKY CLAUDE BARBERIS | United States United States United States United States United States United States United States United States United States United States United States United States United States | ||
| 2022-09-02 | PCTUS2022075875 | INDOLE COMPOUNDS AND METHODS OF USE | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | JUNKAI LIAO MARK MUNSON SUKANTHINI THURAIRATNAM BRADFORD HIRTH ZHONGLI GAO GREGORY HURLBUT DAVID BORCHERDING MATTHIEU BARRAGUE TIMOTHY ALAN GILLESPY ALEXANDRE GROSS THADDEUS NIEDUZAK ANDREW GOOD ROY VAZ JINYU LIU YI LI MARKUS METZ ANATOLY RUVINSKY MICHAEL KOTHE | United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States | ||
| 2022-08-23 | 63400384 | THERAPEUTIC RECEPTOR-INTERACTING SERINE/ | Genzyme Corporation | Provisional Application Expired | Nazem Atassi Catherine Cantalloube Agnès Hincelin-Mery Donato Teutonico | United States France France France | ||
| 2022-07-08 | 63359717 | METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA | Genzyme Corporation | Provisional Application Expired | José Bartelt-Hofer | France | ||
| 2022-07-08 | 63359695 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN | Genzyme Corporation | Provisional Application Expired | Shauna Andersson Baisong Mei Fadi Shammas Christian Sussebach | United States United States Canada Germany | ||
| 2022-06-30 | 63357465 | THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MULTIPLE SCLEROSIS AND MYASTHENIA GRAVIS | Genzyme Corporation | Provisional Application Expired | Sana Syed | United States | ||
| 2022-06-22 | 63354448 | SOLID FORMS OF DEUTERATED COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS | Genzyme Corporation | Provisional Application Expired | Pierre deMontigny Craig S. Siegel Donglai Yang | United States United States United States | ||
| 2022-06-22 | 63354330 | METHODS OF MAKING MODIFIED BTK INHIBITORS | Genzyme Corporation | Provisional Application Expired | John L. Kane JR. Timothy D. Owens Timothy J. Turner | United States United States United States | ||
| 2022-06-17 | PCTUS2022034103 | ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | KIRAN RANA BANGARI SANKET PATKE TIMOTHY MCCOY RAMIL LATYPOV | United States United States United States United States | ||
| 2022-06-17 | 17843812 | ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE | Genzyme Corporation | Final Rejection Mailed | US20230036928A1 | Kiran Rana BANGARI Ramil LATYPOV Timothy MCCOY Sanket PATKE | United States United States United States United States | BERHANE, SELAM |
| 2022-06-16 | 17842528 | Methods for Improving Cell Viability In A Production BioReactor | Genzyme Corporation | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20220308042A1 | Jonathan Wang Neha Shah Jason Walther Jiuyi Lu Timothy Johnson Yukun Ren Jean McLarty | United States United States United States United States United States United States United States | XU, QING |
| 2022-06-14 | 63351996 | METHODS OF MAKING TOLEBRUTINIB | Genzyme Corporation | Provisional Application Expired | Frédéric Bailly Christophe Benelli Cyril Borie Michaël Bosch Alexis Charaudeau Laurence Janssens François Pacquet Fabien Rodier Laurent Sallé Alfred Sodo Sylvie Vigne Claude Cabos | France France France France France France France France France France France France | ||
| 2022-06-08 | 63350398 | TREATMENT OF HEMOPHILIA WITH FITUSIRAN | Genzyme Corporation | Provisional Application Expired | Shauna Andersson Baisong Mei Fadi Shammas Christian Sussebach | United States United States Canada Germany | ||
| 2022-06-08 | 63350382 | TREATMENT OF PEDIATRIC HEMOPHILIA WITH FITUSIRAN | Genzyme Corporation | Provisional Application Expired | Shauna Andersson Pratik R. Bhagunde Sajida Iqbal Pranav Patel Stacey Poloskey Fadi Shammas | United States United States United States United States United States Canada | ||
| 2022-05-25 | 17824552 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORPORATION | Notice of Allowance Mailed -- Application Received in Office of Publications | US20220409595A1 | John P. LEONARD Jean-François DELEUZE Jean-Michel ITIER Cécile ORSINI Gwénaëlle RET-LECUELLE Sandra VIALE | United States France France France France France | SZNAIDMAN, MARCOS L |
| 2022-05-16 | 63342590 | METHODS OF TREATING METACHROMATIC LEUKODYSTROPHY | Genzyme Corporation | Provisional Application Expired | Shyam Ramachandran | United States | ||
| 2022-05-13 | PCTUS2022029262 | NOVEL PREDICTIVE BIOMARKERS FOR SECONDARY AUTOIMMUNITY AFTER LYMPHOCYTE DEPLETING THERAPY | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | DARREN PHILLIP BAKER EMANUELE DE RINALDIS SRINIVAS SHANKARA EVIS HAVARI VIRGINIA SAVOVA RICHA HANAMSAGAR | United States United States United States United States United States United States | ||
| 2022-05-13 | 63341486 | THERAPEUTIC TYROSINE KINASE INHIBITORS FOR MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY DISEASE (MOGAD) | Genzyme Corporation | Provisional Application Expired | Timothy J. Turner Erik Wallstroem | United States United States | ||
| 2022-05-11 | 17742169 | 5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY | Genzyme Corporation | Patented Case | US20240002374A1 | Junkai Liao Mark Munson Zhongli Gao Gregory Donald Hurlbut Sylvie Baltzer Bertrand Vivet Brian Freed Hans Peter Nestler Helen Yeoman Ingrid Mechin Martin Smrcina Nina Ma Sylvain Lebreton Ryan Hartung William Wire Sukanthini Thurairatnam | United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States United States | SHAMEEM, GOLAM M |
| 2022-05-09 | 17775446 | BIPARATOPIC CD73 ANTIBODIES | GENZYME CORPORATION | Notice of Allowance Mailed -- Application Received in Office of Publications | US20220403041A1 | Dana LORD Katarina RADOSEVIC James E. STEFANO Yanfeng ZHOU | United States France United States United States | AEDER, SEAN E |
| 2022-05-06 | PCTUS2022028117 | COMPOSITION AND METHODS FOR SANITIZATION | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | RYAN F. WOLLENSAK JOSEPH P. KUTZKO | United States United States | ||
| 2022-04-27 | 63335535 | METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA | Genzyme Corporation | Provisional Application Expired | José Bartelt-Hofer | France | ||
| 2022-04-14 | PCTUS2022024781 | METHODS OF PERFUSION CULTURING A MAMMALIAN CELL | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | SHAWN L. BARRETT DARYL POWERS CHARLES BUDDE | United States United States United States | ||
| 2022-04-14 | 17721003 | METHODS OF PERFUSION CULTURING A MAMMALIAN CELL | Genzyme Corporation | Response to Non-Final Office Action Entered and Forwarded to Examiner | US20220333054A1 | Shawn L. Barrett Charles Budde Daryl Powers | United States United States United States | LEVIN, JOEL D |
| 2022-04-12 | 63330245 | USE OF AN IRAK4 MODULATORS FOR GENE THERAPY | Genzyme Corporation | Provisional Application Expired | Sourav Roy CHOUDHURY Mona MOTWANI Christian MUELLER John REED | United States United States United States United States | ||
| 2022-04-12 | 63330241 | DENDRITIC CELL ASSAY FOR INNATE IMMUNOGENICITY TO GENE THERAPY AGENTS | Genzyme Corporation | Provisional Application Expired | Sourav CHOUDHURY Mona MOTWANI | United States United States | ||
| 2022-04-12 | 63330239 | USE OF IRAK4 MODULATORS FOR GENE THERAPY | Genzyme Corporation | Provisional Application Expired | Sourav Roy CHOUDHURY Mona MOTWANI Christian MUELLER John REED | United States United States United States United States | ||
| 2022-04-06 | 63328241 | TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY | Genzyme Corporation | Provisional Application Expired | Seng CHENG Sarah Melissa JACOBO Takako MORIGUCHI Catherine O’RIORDAN Guoxiang RUAN | United States United States United States United States United States | ||
| 2022-03-28 | 63324292 | Process For Preparing SHP2 Inhibitors | Genzyme Corporation | Provisional Application Expired | Davide Gornati Fabio Morana Jacopo Roletto | Italy Italy Italy | ||
| 2022-03-21 | PCTUS2022071245 | SIZE EXCLUSION CHROMATOGRAPHY ANALYSIS OF EMPTY AND FULL AAV CAPSIDS | GENZYME CORPORATION | RO PROCESSING COMPLETED-PLACED IN STORAGE | HE MENG | United States | ||
| 2022-03-21 | 63322133 | METHODS OF PROCESSING A FLUID | Genzyme Corporation | Provisional Application Expired | Michael Coolbaugh Shashi Malladi | United States United States | ||
| 2022-03-18 | 63321636 | Pharmaceutical Recombinant Human Acid Sphingomyelinase Compositions and Methods | Genzyme Corporation | Provisional Application Expired | Thomas M. Wasylenko Kevin Brower Xiaoying Jin | United States United States United States | ||
| 2022-02-01 | 63305550 | METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA | Genzyme Corporation | Provisional Application Expired | José Bartelt-Hofer | France |